On November 29, 2017, Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Decibel Therapeutics, Inc. announced a collaboration to discover and develop new potential therapeutics to protect, repair and restore hearing.
WilmerHale's representation of Decibel Therapeutics was led by Steven Singer, Lia Der Marderosian, Kaylan Sliney and Alex Civetta.
ReadĀ Decibel's press release to learn more.